Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke

More than half of all ischemic stroke patients exhibit a clinical syndrome with mild neurological deficit [1, 2]. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) within 4.5 h has been proven to be an effective treatment for acute ischemic stroke, but its benefits and risks in mild strokes are still unclear [3]. When patients with a mild stroke received intravenous thrombolytic therapy, approximately 30% of them had an unfavorable outcome [3‐5]. Thus, it is of great importance to identify the patients at risk of unfavorable outcomes in the acute phase to prevent neurological deterioration and to predict outcomes in minor ischemic strokes treated with intravenous thrombolysis.

Magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) is superior to computed tomography (CT) for early detection of hyperacute and small ischemic lesions. Pretreatment DWI lesion patterns may be helpful in predicting clinical outcome in patients with acute ischemic stroke [6, 7]. Steno-occlusive lesions of the cerebral artery are associated with unfavorable outcomes in patients with minor strokes [8, 9]. However, it is unclear whether the pretreatment lesions pattern on DWI and the presence of steno-occlusive lesions in relevant arteries can predict outcome following rt-PA thrombolysis in patients with minor stroke.

The aim of our study was to elucidate the clinical and pretreatment radiological factors associated with an unfavorable outcome after intravenous thrombolysis in patients with minor stroke.

We identified 682 consecutive patients in our prospectively collected institutional stroke database treated with intravenous rt-PA therapy within 4.5 h after symptom onset, independent of performance of emergent endovascular treatment between January 2010 and December 2016. During this period, MRI was systematically adopted at our center as the first-line imaging modality [DWI, fluid-attenuated inversion recovery, gradient echo sequences, and time of flight magnetic resonance angiography (MRA)] in the absence of contraindications to MRI. Eligible patients were treated with intravenous rt-PA according to clinical guidelines. No upper or lower National Institutes of Health Stroke Scale (NIHSS) threshold was applied. Follow up MRI or CT were performed 24 h after intravenous rt-PA thrombolysis in all patients.

Patients were included in our study if they had an anterior circulation stroke with an initial NIHSS score of 1 to 5 and pretreatment MRI including DWI and MRA. We excluded patients who; (1) had a pre-stroke modified Rankin scale core (mRS) > 1, (2) received subsequent endovascular treatment combined with intravenous thrombolysis, (3) had no definitive evidence of focal hyperintensities in clinically relevant areas on initial or follow up DWI, or (4) had no follow-up data.

Demographic, clinical and laboratory data were collected from the prospectively collected stroke registry. Baseline data included initial NIHSS scores and onset-to-rt-PA treatment times. Mild stroke was defined as a baseline NIHSS score 1–5 [5]. The etiologic stroke subtype was defined according to the Trial of Org 10,172 in Acute Stroke Treatment (TOAST) criteria [10].

This study was approved by the Institutional Review Board of Dong-A University Hospital.

A total of 202 patients with baseline NIHSS ≤5 were treated with intravenous thrombolysis. We excluded 42 patients with posterior circulation strokes, 18 patients without hyperintensity lesions on pretreatment and follow-up DWI, 5 patients who received endovascular treatment, 5 patients with an initial NIHSS of 0, 5 patients with unavailable or insufficient quality DWI, 3 patients with mRS 2–6 prior to the stroke, and 3 patients without an mRS assessment at 3 months Finally, 121 patients (85 men and 36 women; mean age, 63.4 ± 11.3 years) were included in the study (Fig. 2). The median baseline NIHSS score was 4 (interquartile range, 3–5). Among 121 patients, 46 (38%) had unfavorable outcomes (mRS score 2–6) at 90 days. Symptomatic intracerebral hemorrhages were rare (1.7%).

Table 1 presents the general characteristics and radiologic features of patients with and without unfavorable outcomes. In univariate analysis, diabetes (P = 0.007), non-cardiac embolism (P = 0.04), higher NIHSS scores (P = 0.003), and deep MCA territory infarction (P < 0.001) were more frequently observed in patients with an unfavorable outcome. The onset-to-rt-PA time was 141.6 ± 58 and 145.6 ± 67 min in the favorable and unfavorable groups, respectively, and did not differ significantly (P = 0.728). Visible arterial occlusion before rtPA was observed in 33% of patients. They were comprised of ICA occlusion (N = 8), M1 proximal occlusion (N = 10), M1 distal occlusion (N = 11), M2 occlusion (N = 9), and ACA occlusion (N = 2) on MRA. There was no difference in favorable outcome following intravenous thrombolysis between mild stroke patients with and without large artery occlusion.

After univariate analysis, hyperlipidemia (P = 0.058), age, sex, previous stroke, and steno-occlusive disease (P = 0.181) were also included in the multivariate logistic regression. Multivariate logistic regression analysis showed that diabetes [odds ratio (OR), 3.41; 95% confidence interval (CI), 1.06–10.9; P = 0.039], higher NIHSS scores on admission (OR, 2.11; 95% CI, 1.35–3.30; P = 0.001), and infarction in the deep MCA territory (OR, 4.19; 95% CI, 1.63–10.8; P = 0.003) were independently associated with unfavorable outcome (Table 2).

A DWI lesion pattern with infarction in the deep MCA territory (Group A) was observed in 47 (38.8%) patients. Group A was independently associated with END (P = 0.032) and moderate to severe (> 50%) stenosis in the relevant artery (P = 0.019). The patients without lesions in the deep MCA territory (Group B) had a higher prevalence of cardiac embolism (P = 0.009) (Additional file 1: Table S1, Fig. 3).

This study showed that a large proportion (38%) of patients receiving intravenous thrombolysis for minor strokes will have an unfavorable outcome at 90 days. Symptomatic intracerebral hemorrhages were rare. Baseline NIHSS score, diabetes mellitus, and deep MCA infarction with lesions in the perforating artery territory were independently associated with unfavorable outcomes.

According to recent reports, age [5, 13], diabetes mellitus [5, 8, 9, 14], previous stroke [14], intra-or extracranial vascular occlusive lesions [8, 9] and NIHSS score [5, 15] were associated with unfavorable outcomes in patients with minor strokes. However, these studies explored the factors associated with disability at 90 days in mild stroke patients not treated with thrombolytic therapy.

It remains to be determined whether the presence of steno-occlusive lesions leads to unfavorable outcomes in mild stroke patients following intravenous rt-PA treatment. As opposed to previous reports on non-thrombolytic therapy [8, 9], we did not find an association between large artery occlusion and unfavorable outcome following intravenous rt-PA therapy. This is in line with previous reports that also found no differences in outcome following intravenous thrombolysis between mild stroke patients with and without large artery occlusion [16, 17]. Mild stroke patients tend to have more distal artery occlusion, lower thrombus burden, and higher recanalization rates or have central occlusions with good collaterals [18‐20]. This might be the reason why even patients with large artery occlusion do not have different outcome following intravenous rt-PA therapy compared to those without.

Previous studies have shown that acute lesion patterns may predict prognosis or stroke recurrence after ischemic stroke [11, 21] but it remains unclear whether such imaging factors are related to patient outcome after intravenous thrombolysis in mild ischemic stroke. Patients with perforating artery infarcts in the basal ganglia and corona radiata were more likely to have unfavorable outcomes in this study. These finding may be explained by several hypothesis.

First, Strambo et al. [15] reported that among all NIHSS items, only impairment of motor items is significantly associated with poor outcome in mild stroke. Since the deep MCA territory is crossed by the corticospinal tract [22] and is prone to damage by poor collateral flow [23], this area may be susceptible to motor deficits, regardless of rt-PA thrombolysis. In some reports, patients with deep white matter or basal ganglia infarction have suffered from bad outcomes after thrombolysis or endovascular therapy [7, 22, 23]. Thus, even small lesions in this area could be critical to the outcome of mild ischemic stroke.

Second, END is an important factor associated with worse clinical outcome in minor strokes [9]. Several patients with infarcts in the perforator territory have END (29.1%) [13] and this rate was similar to that in patients with small vessel disease that received intravenous rt-PA therapy (33%) [24]. In our study, ENDs were more prevalent in Group A patients and were associated with unfavorable outcomes. These results may have important clinical implications. Previous study has shown that rt-PA use in acute lacunar stroke does not affect END [24]. Thus, special attention should be paid to patients with infarcts in the perforating territory, even when they show mild neurological deficits at the time of presentation and after rt-PA therapy.

Lastly, Group B was more likely to have cardiac embolism. This can be explained by a previous report that demonstrated a mild stroke caused by cardiac embolism could reveal small cortical lesions and lead to a high rate of neurological improvement [15]. However, Hao et al. [25] reported that in mild stroke, cardiac embolism was a predictor of death or disability at 3 months and that patients with small vessel occlusion had better outcomes. That study enrolled mild stroke patients within 30 days after stroke onset. There is a possibility that non-cardiac embolism patients with early worsening or early recurrence were excluded from that study, whereas we included patients treated with rt-PA therapy within 4.5 h. Further studies are needed to confirm whether cardiac embolism can be a protective factor in ischemic stroke with mild symptoms.

A significant strength of our study is that all patients underwent pretreatment MRI. DWI has the advantage of capturing small infarctions and detection of early ischemic changes in patients with acute mild ischemic stroke, unlike CT. Few studies on whether pretreatment DWI lesions pattern and arterial occlusion on MRA can predict outcome in mild stroke are available [21, 26]. To the best of our knowledge, this is the largest study to investigate the DWI findings in patients with mild stroke treated with rt-PA therapy.

The most notable limitation of our study is the uncontrolled, non-randomized design since this was a single hospital-based study. Limitations to using clinical registry data may include the introduction of bias in patient selection including the imbalance of sex ratio in this study. Thus, generalizing the results of this study to other patient populations may be challenging.

We found that in spite of intravenous rt-PA treatment, approximately 40% of anterior circulation stroke patients with minor symptom had unfavorable outcomes at 3 months. Higher NIHSS scores, diabetes and deep MCA infarction with involvement of the perforating artery territory were associated with unfavorable outcomes after rt-PA therapy in patients with minor stroke. Brain MRI-DWI patterns assessed in the acute phase of mild stroke are useful to predict those patients at high risk of unfavorable outcome following rt-PA therapy.